TheraVet Balance Sheet Health
Financial Health criteria checks 3/6
TheraVet has a total shareholder equity of €6.0M and total debt of €1.2M, which brings its debt-to-equity ratio to 19.2%. Its total assets and total liabilities are €7.5M and €1.5M respectively.
Key information
19.2%
Debt to equity ratio
€1.16m
Debt
Interest coverage ratio | n/a |
Cash | €1.15m |
Equity | €6.05m |
Total liabilities | €1.48m |
Total assets | €7.53m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 31A's short term assets (€1.6M) exceed its short term liabilities (€484.4K).
Long Term Liabilities: 31A's short term assets (€1.6M) exceed its long term liabilities (€1.0M).
Debt to Equity History and Analysis
Debt Level: 31A's net debt to equity ratio (0.2%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if 31A's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 31A has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: 31A has less than a year of cash runway if free cash flow continues to reduce at historical rates of 1.4% each year